The targeted therapies class has fueled most of the recent rapid growth of the oncology market as a whole. In the next decade the market will become more fragmented as new targeted therapies are developed for niche populations. In addition to this, recent pricing restrictions in the Eurozone will impact sales growth of targeted cancer therapies in the five major EU markets....More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Louis
+1 718 618 4302
"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...
"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. ...
STUDY GOALS AND OBJECTIVES This BCC Research report, RNAi: Technologies and Global Markets, provides an overview of the current state of the RNA interference (RNAi) market, focusing specifically on RNAi ...
... Approvals were obtained prior to study initiation ziebe et al. 2013 In press, fertility & sterility design demonstrate that addition of 2 ng/ml gm-csf to the control medium would increase the ongoing ...
... Stanton l. Gerson, md mesenchymal stem cells: clinical application and outlook the cwru experience asa & patricia shiverick and jane shiverick (tripp) professor of hematological oncology ...
Reportlinker.com © Copyright 2013. All rights reserved.